Intuitive Surgical (NASDAQ: ISRG) EVP nets 4,853-share insider sale

Rhea-AI Filing Summary

Intuitive Surgical EVP & Chief Medical Officer Myriam Curet reported net insider sales of common stock through a trust. A trust associated with her sold 4,728 shares on March 3, 2026 at an average price of $487.18 per share, leaving 409 indirectly owned shares.

On March 2, 2026, a non-qualified stock option for 125 shares was exercised and converted into common stock at an exercise price of $208.90 per share, and those 125 shares were then sold the same day at $492.59 per share. The option position now shows zero shares remaining. The transactions were carried out under a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		M(1)		125	A	$208.9	5,262	I	by Trust
Common Stock	03/02/2026		S(1)		125	D	$492.59	5,137	I	by Trust
Common Stock	03/03/2026		S(1)		4,728	D	$487.18	409	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$208.9	03/02/2026		M(1)			125	(2)	08/28/2029	Common Stock	125	$0.0	0	D

Explanation of Responses:

1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.

2. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

	By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Intuitive Surgical (ISRG) report for Myriam Curet?

Myriam Curet reported a combination of stock option exercise and share sales. A trust associated with her sold 4,853 Intuitive Surgical common shares in total, including 4,728 shares on March 3, 2026 and 125 shares on March 2, 2026, following an option exercise.

How many Intuitive Surgical (ISRG) shares did the EVP & Chief Medical Officer sell?

The transactions reflect net sales of 4,853 Intuitive Surgical shares. A trust associated with the EVP & Chief Medical Officer sold 4,728 shares at $487.18 on March 3, 2026 and 125 shares at $492.59 on March 2, 2026 in open-market transactions.

Were the Intuitive Surgical (ISRG) insider sales made under a 10b5-1 plan?

Yes, the insider sales were executed under a Rule 10b5-1 trading plan. The filing states the transactions took place according to a Trading Plan that complies with SEC Rule 10b5-1 and that this plan is scheduled to expire on July 29, 2026.

What stock option activity did Myriam Curet report at Intuitive Surgical (ISRG)?

She reported exercising a non-qualified stock option for 125 shares. The option, granted under the 2010 Incentive Award Plan, was exercised at an exercise price of $208.90 per share on March 2, 2026, converting into common stock that was then sold the same day.

How many Intuitive Surgical (ISRG) shares does the reporting person hold after these transactions?

After the reported transactions, the trust holds 409 Intuitive Surgical shares. Following the March 3, 2026 open-market sale, the total indirectly owned common stock reported as held by the trust is 409 shares, with the exercised option position showing no remaining derivative shares.

What is the role of the trust in these Intuitive Surgical (ISRG) insider transactions?

The common stock transactions are reported as indirect holdings through a trust. The Form 4 identifies ownership of the sold and remaining common shares as “by Trust,” indicating the shares are held indirectly rather than as directly owned stock by the executive.